Semantically enabling pharmacogenomic data for the realization of personalized medicine
- PMID: 22256869
- PMCID: PMC3957334
- DOI: 10.2217/pgs.11.179
Semantically enabling pharmacogenomic data for the realization of personalized medicine
Erratum in
- Pharmacogenomics. 2012 Apr;13(5):628
Abstract
Understanding how each individual's genetics and physiology influences pharmaceutical response is crucial to the realization of personalized medicine and the discovery and validation of pharmacogenomic biomarkers is key to its success. However, integration of genotype and phenotype knowledge in medical information systems remains a critical challenge. The inability to easily and accurately integrate the results of biomolecular studies with patients' medical records and clinical reports prevents us from realizing the full potential of pharmacogenomic knowledge for both drug development and clinical practice. Herein, we describe approaches using Semantic Web technologies, in which pharmacogenomic knowledge relevant to drug development and medical decision support is represented in such a way that it can be efficiently accessed both by software and human experts. We suggest that this approach increases the utility of data, and that such computational technologies will become an essential part of personalized medicine, alongside diagnostics and pharmaceutical products.
Figures
References
-
- Hafner JW, Jr, Belknap SM, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann. Emerg. Med. 2002;39(3):258–267. - PubMed
Websites
-
- RDF Primer. W3C recommendation. www.w3.org/TR/rdf-primer.
-
- OWL: Web Ontology Language Overview. www.w3.org/TR/owl-features.
-
- D2R server – publishing relational databases on the Semantic. Web. www4.wiwiss.fu-berlin.de/bizer/d2r-server.
-
- Virtuoso Open-Source Wiki: Virtuoso Open-Source Edition. www.openlinksw.com/wiki/main/Main.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources